Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

Share:
More In Business
The Top Jobs to Look For in 2023
Scott Dobroski, career trend expert at Indeed, joined Cheddar News to discuss job trends in 2023 as the U.S. labor market remains robust despite some high-profile layoffs.
2023 Traders' Survival Kit
Ed Egilinsky, Managing Director, Head of Sales and Distribution & Alternatives at Direxion, joins Cheddar News to discuss how traders are navigating rising interest rates, the pros and cons to a 'risk on' mindset, and what to keep an eye out for as earnings season heats up.
Load More